arrow
B

Babak Sharif-Kashani

Shahid Beheshti University of Medical Sciences
H指数:17
被引数:1,793

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Report on adverse events of COVID-19 vaccines in Iran: a comprehensive national prospective longitudinal analysis
2025-02-140
OAAI
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial
2023-05-124
OA
Atorvastatin Versus Placebo In Icu Patients With Covid19: Ninety-day Results Of The INSPIRATION-S Trial
2023-05-010
PRE
Machine Learning To Identify Heterogeneity Of Treatment Effect Of Intermediate-dose Vs Standard-dose Prophylactic Anticoagulation In The Inspiration Trial
2023-05-010
PRE
Donor heart selection: Evidence-based guidelines for providers
2023-01-0151
OAAI
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
2021-06-0659
OAAI
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial
2021-04-27487
OA
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
2020-12-0151
OAAI